American Journal of Epidemiology Vol. 148, No. 10: 975-982
Copyright © 1998 by The Johns Hopkins University School of Hygiene and Public Health
other |
Is Low Selenium Status a Risk Factor for Lung Cancer?
1National Public Health Institute Helsinki, Finland
2Social Insurance Institution Turku, Finland
3Finnish Cancer Registry Helsinki, Finland
Reprint requests to Dr. Paul Knekt, National Public Health Institute, Mannerheimintie 166, 00300 Helsinki, Finland.
The hypothesis that low selenium may in some circumstances be a risk factor for lung cancer was investigated in a case-control study nested within a longitudinal study. Serum samples from 9, 101 cancer-free individuals were collected and stored at -20°C by the Finnish Mobile Clinic in 1968–1971 and 1973–1976. During follow-up until the end of 1991, 95 cases of lung cancer were diagnosed. Selenium concentrations were determined from the serum samples of the cases and 190 controls, individually matched for sex, age, and place of residence. Mean levels of serum selenium in cases and controls were 53.2 µg/liter and 57.8 µg/liter, respectively. The relative risk of lung cancer between the highest and lowest tertiles of serum selenium, adjusted for smoking, serum alpha-tocopherol, serum cholesterol, serum copper, serum orosomucoid, and body mass index (kg/m2), was 0.41 (95% confidence interval (Cl) 0.17–0.94). The association was stronger at lower levels (<5.9 mg/liter) of alpha-tocopherol (relative risk = 0.24, 95% Cl 0.07–0.85). The association was also pronounced among current smokers and at higher levels of serum orosomucoid and serum copper. The relative risk for smokers who were twice ranked in higher selenium tertiles, at an interval of 4–7 years, in comparison with smokers who remained in the lowest tertile was 0.16 (95% Cl 0.04–0.74). In accordance with the hypothesis, the findings suggest that very low selenium status may contribute to the risk of lung cancer. Am J Epidemiol 1998; 148:975—82.
follow-up studies; lung; neoplasms; selenium; serum
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Mattila, P. Knekt, S. Mannisto, H. Rissanen, M. A. Laaksonen, J. Montonen, and A. Reunanen Serum 25-Hydroxyvitamin D Concentration and Subsequent Risk of Type 2 Diabetes Diabetes Care, October 1, 2007; 30(10): 2569 - 2570. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Marshall, W. Sakr, D. Wood, D. Berry, C. Tangen, F. Parker, I. Thompson, S. M. Lippman, R. Lieberman, D. Alberts, et al. Design and Progress of a Trial of Selenium to Prevent Prostate Cancer among Men with High-Grade Prostatic Intraepithelial Neoplasia. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1479 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hu, R. V. Benya, R. E. Carroll, and A. M. Diamond Allelic Loss of the Gene for the GPX1 Selenium-Containing Protein Is a Common Event in Cancer J. Nutr., December 1, 2005; 135(12): 3021S - 3024S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Diwadkar-Navsariwala and A. M. Diamond The Link between Selenium and Chemoprevention: A Case for Selenoproteins J. Nutr., November 1, 2004; 134(11): 2899 - 2902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhuo, A. H. Smith, and C. Steinmaus Selenium and Lung Cancer: A Quantitative Analysis of Heterogeneity in the Current Epidemiological Literature Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 771 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Saito, Y. Yoshida, T. Akazawa, K. Takahashi, and E. Niki Cell Death Caused by Selenium Deficiency and Protective Effect of Antioxidants J. Biol. Chem., October 10, 2003; 278(41): 39428 - 39434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Hu and A. M. Diamond Role of Glutathione Peroxidase 1 in Breast Cancer: Loss of Heterozygosity and Allelic Differences in the Response to Selenium Cancer Res., June 15, 2003; 63(12): 3347 - 3351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Reid, A. J. Duffield-Lillico, L. Garland, B. W. Turnbull, L. C. Clark, and J. R. Marshall Selenium Supplementation and Lung Cancer Incidence: An Update of the Nutritional Prevention of Cancer Trial Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1285 - 1291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Duffield-Lillico, M. E. Reid, B. W. Turnbull, G. F. Combs Jr., E. H. Slate, L. A. Fischbach, J. R. Marshall, and L. C. Clark Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: A Summary Report of the Nutritional Prevention of Cancer Trial Cancer Epidemiol. Biomarkers Prev., July 1, 2002; 11(7): 630 - 639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Goodman, S. Schaffer, D. D. Bankson, M. P. Hughes, and G. S. Omenn Predictors of Serum Selenium in Cigarette Smokers and the Lack of Association with Lung and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2001; 10(10): 1069 - 1076. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jun Hu, K. V. Korotkov, R. Mehta, D. L. Hatfield, C. N. Rotimi, A. Luke, T. E. Prewitt, R. S. Cooper, W. Stock, E. E. Vokes, et al. Distribution and Functional Consequences of Nucleotide Polymorphisms in the 3'-Untranslated Region of the Human Sep15 Gene Cancer Res., March 1, 2001; 61(5): 2307 - 2310. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. D. Mark, Y.-L. Qiao, S. M. Dawsey, Y.-P. Wu, H. Katki, E. W. Gunter, J. F. Fraumeni Jr., W. J. Blot, Z.-W. Dong, and P. R. Taylor Prospective Study of Serum Selenium Levels and Incident Esophageal and Gastric Cancers J Natl Cancer Inst, November 1, 2000; 92(21): 1753 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kumaraswamy, A. Malykh, K. V. Korotkov, S. Kozyavkin, Y. Hu, S. Y. Kwon, M. E. Moustafa, B. A. Carlson, M. J. Berry, B. J. Lee, et al. Structure-Expression Relationships of the 15-kDa Selenoprotein Gene. POSSIBLE ROLE OF THE PROTEIN IN CANCER ETIOLOGY J. Biol. Chem., November 3, 2000; 275(45): 35540 - 35547. [Abstract] [Full Text] [PDF]
|
|